It is sad that they have discontinued right to try as we know leronlimab saves lives of critical/severe covid. I understand the decision because lots of paperwork and time for each request has to be done and cydy still small work force. Hopefully it will be all hands on deck to get Brazil patients enrolled and data collected and analyzed.